
AesculaTech YCアプリケーション
AesculaTechはWinter 2018バッチでHealthcare企業としてY Combinatorを卒業しました。以下:会社の事業内容、創業者、そして実際のYCフォームで質問ごとに再構築されたYCへの応募内容。
- YCバッチ
- Winter 2018
- 業界
- HealthcareMedical Devices
- チーム規模
- 6
- ステータス
- Active
- ローンチ済み
- 2017
創業者
Niki BayatFounder/CEO
AesculaTechの事業内容
AesculaTech believes in building better lives through smart chemistry. We design custom smart materials for a range of biomedical, commercial, and industrial applications. Our platform technology, AesculaGel offers adaptive response to a wide range of stimuli and can be tailor-made for biocompatibility, material strength, and a range of other attributes. Founded by one of MIT's 35 under 35 Innovators, AesculaTech is the shared vision of scientists, engineers, and medical experts. Our cornerstone product, Humidifeye, is an ophthalmic platform to treat dry eye disease. Dry eye affects more than 25 million Americans and the global treatment market is projected higher than $6 Billion within the next decade. Our thermally responsive, form-fitting materials are suitable for sustained yet reversible occlusion across a range of treatment times. In contrast to existing technologies, our product will not extrude, or cause discomfort as it adapts to patients. Though Humidifeye is not yet FDA approved, expect to hear about it soon! In coordination with partners across several sectors, we have a variety of groundbreaking technologies in the works that live up to our vision. This work has already been recognized. AesculaTech was named a Rosenman Innovator, received a National Science Foundation I-Corps grant, was a finalist in the 2019 Octane High Tech Awards, and is a graduate of both the Y Combinator and TMCx accelerator programs. In short, Y-Combinator was only the beginning.
AesculaTechのYCアプリケーション、再構築済み
Y Combinator 申請
AesculaTech 様、Winter 2018 バッチ。公開データから回答された、実際のフォームの質問。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
AesculaTech
Responsive materials, better lives.
We make AesculaGel, a smart, adaptive material platform that responds to stimuli and can be tailor-made for strength and biocompatibility. Our lead product, Humidifeye, uses these materials for sustained, comfortable treatment of dry eye disease by providing thermally responsive, form-fitting occlusion that adapts to patients instead of causing discomfort or extrusion like current options.
We live in Los Angeles, CA, and we would continue to be based here after YC.
Los Angeles is our home base with access to local medical experts and manufacturing partners. Staying here keeps our team close and connected to the relevant biomedical ecosystem.
よくある質問
AesculaTechの実際のYCアプリケーションですか?
いいえ。Y Combinatorは提出されたアプリケーションを非公開にしています。これは再構築されたものです。実際のYCフォームの質問に、AesculaTechの公開データ(ローンチノート、創業者経歴、製品説明)から回答しています。AesculaTechのような会社がYCにどのようにアピールするかを示しており、彼らが提出したテキストではありません。
AesculaTechはどのYCバッチに参加しましたか?
AesculaTechはY CombinatorのWinter 2018バッチに参加しました。
AesculaTechは誰によって設立されましたか?
AesculaTechはNiki Bayatによって設立されました。
AesculaTechは何をしていますか?
Responsive materials, better lives.
完全な再構築されたアプリケーションはどのように読めばよいですか?
無料のRound Fundedアカウントを作成してください。 AesculaTechの26つの回答からなる完全なアプリケーションと、他のすべてのYCバッチはYC Insightsにあります。